For a COVID‑19 positive patient, what laboratory, imaging, and therapeutic orders are indicated based on disease severity?

What to Order for a COVID-19 Positive Patient

Do not order routine antibiotics, chest imaging, or daily labs for stable COVID-19 patients—instead, stratify by disease severity and order based on clinical justification, risk factors, and objective signs of respiratory compromise. 1

Initial Assessment & Severity Stratification

Upon confirming COVID-19 positivity, immediately classify disease severity:

• Mild: Fever, URI symptoms, GI symptoms, NO respiratory distress, normal oxygen saturation, normal imaging
• Moderate: Lower respiratory disease on exam/imaging, SpO2 ≥94% on room air
• Severe: SpO2 <94% on room air, PaO2/FiO2 <300 mmHg, respiratory rate >30/min, or lung infiltrates >50%
• Critical: ICU criteria, mechanical ventilation, ARDS, septic shock, multi-organ dysfunction 1

Laboratory Orders by Severity

Mild Disease (Outpatient/Low-Risk)

Order minimal labs:

• No routine laboratory testing required
• Consider baseline inflammatory markers ONLY if risk factors present (age >65, cardiovascular disease, diabetes, chronic respiratory disease, hypertension, immunocompromised) 2

Moderate to Severe Disease (Hospitalized)

Order comprehensive workup:

• Complete blood count with differential: Look for lymphopenia (absolute lymphocyte <0.8 × 10⁹/L), elevated WBC, elevated neutrophils 3, 4
• Inflammatory markers:
  • CRP (elevated suggests bacterial superinfection risk)
  • Procalcitonin (PCT >0.5 ng/mL suggests bacterial infection) 1
  • IL-6 and IL-10 (elevated in 95% and 51% of severe cases respectively) 5
• Coagulation studies: D-dimer (elevated indicates thrombosis risk and need for intensified prophylaxis) 6, 4
• Organ function panels:
  • LDH, AST (elevated in severe disease) 4
  • BNP, HCO3⁻, base excess (correlate with CT severity) 7
  • Renal and hepatic function
• Arterial blood gas if SpO2 <94% 6, 7

Critical Disease (ICU)

Order all above PLUS:

• CD4 and CD8 T cell counts (significant decrease warrants attention) 3
• Comprehensive microbiologic workup BEFORE starting empirical antibiotics (blood cultures, respiratory cultures, fungal markers if indicated) 1
• Serial inflammatory markers to guide therapy

Imaging Orders by Severity

Mild Disease

Do NOT order routine imaging 2, 8, 2

Order chest imaging (chest X-ray preferred for portability/infection control) ONLY if:

• Risk factors for progression present (age >65, comorbidities) 2
• Clinical worsening develops (96% consensus supports imaging) 2

Moderate to Severe Disease (Hospitalized)

Order chest imaging on admission (92-100% consensus supports this) 2:

• Chest X-ray as first-line (portable, reduces transmission risk, adequate for hospitalized patients presenting late in disease course) 2
• CT chest if:
  • Chest X-ray inconclusive
  • Evaluating disease progression
  • Assessing complications (bacterial superinfection, pneumothorax, pleural effusion, pulmonary embolism with IV contrast) 2
  • Residual functional impairment/hypoxemia after recovery (88% support) 2

Do NOT order daily chest X-rays in stable intubated patients (83% against) 2

Clinical Worsening

Order repeat imaging immediately regardless of initial COVID-19 test results (96% consensus) 2

Therapeutic Orders by Severity

Mild Disease

• Antivirals (if within appropriate treatment window per current guidelines) 9
• NO routine antibiotics 1
• Supportive care

Moderate to Severe Disease

• Dexamethasone (decreases mortality in severe/critical COVID-19) 6
• Thromboprophylaxis: Standard or intensified based on risk factors (obesity, known thrombophilia, ICU admission, elevated D-dimers) 6
• High-flow oxygen or non-invasive ventilation for hypoxemic respiratory insufficiency 6
• Consider methylprednisolone + human immunoglobulin for progressive ARDS (early intervention improves prognosis) 5

Antibiotics—Only When Clinically Justified

Order empirical antibiotics ONLY if 1:

• Critically ill/ICU patients (higher CABI risk)
• Clinical signs of bacterial superinfection (lobar consolidation on imaging)
• PCT >0.5 ng/mL with compatible clinical picture
• After obtaining microbiologic cultures

Antibiotic selection:

• Non-ICU: Cover typical + atypical CAP pathogens 1
• ICU/critically ill: Add anti-MRSA coverage in selected patients 1

Critical Pitfalls to Avoid

1. Do not reflexively order antibiotics—bacterial coinfection occurs in <10% at presentation; secondary infections develop after 48 hours of hospitalization 1
2. Do not order imaging for mild disease without risk factors—77-88% of experts recommend against this 2
3. Do not use biomarkers alone to decide antibiotic initiation in non-critically ill patients 1
4. Do not skip microbiologic workup before starting antibiotics—this prevents appropriate de-escalation 1
5. Do not forget thromboprophylaxis in hospitalized patients, especially with elevated D-dimers 6